<p>Hinge Health Inc.（纽约证券交易所代码：HNGE - 获取免费报告）在 12 月份的空头头寸显著增加。截至 12 月 15 日，空头头寸总计为 4,180,660 股，比 11 月 30 日的 1,922,965 股增加了 117.4%。根据平均每日交易量 1,473,836 股，目前的覆盖天数比率为 2.8 天。大约 5.3% 的公司股份被做空。</p>
<h2>Hinge Health 的内部活动</h2>
<p>在相关消息中，首席执行官 Daniel Antonio Perez 于 12 月 15 日星期一出售了 166,670 股公司的股票，交易价格为每股平均 48.53 美元，总价值为 8,088,495.10 美元。该交易在向 SEC 的法律文件中披露，相关文件可通过此链接获取。此外，首席财务官 James Budge 于 11 月 25 日星期二出售了 44,589 股公司的股票，交易价格为每股平均 47.47 美元，总价值为 2,116,639.83 美元。出售后，首席财务官直接持有 479,878 股公司的股票，估值约为 22,779,808.66 美元。此交易代表其持股减少了 8.50%。该销售的 SEC 文件提供了更多信息。在过去三个月中，内部人士共出售了价值 120,486,691 美元的 2,638,440 股公司股票。</p>
<h2>机构投资者对 Hinge Health 的看法</h2>
<p>大型投资者最近调整了对公司的持股。Sandler Capital Management 在第三季度将其在 Hinge Health 的股份增加了 1.4%。Sandler Capital Management 目前持有 52,728 股公司的股票，价值 2,588,000 美元，此前在上个季度购买了 728 股。Mirae Asset Global Investments Co. Ltd.在第三季度购买了 Hinge Health 的新股份，价值约 37,000 美元。Montag A &amp; Associates Inc.在第二季度获得了 Hinge Health 的新头寸，价值约 41,000 美元。Jones Financial Companies Lllp 在第三季度将其在 Hinge Health 的持股增加了 348.0%。Jones Financial Companies Lllp 目前持有 1,120 股公司的股票，估值 54,000 美元，此前在上个季度增加了 870 股。最后，SBI Securities Co. Ltd.在第二季度获得了 Hinge Health 的新股份，价值约 48,000 美元。</p>
<h2>分析师的升级与降级</h2>
<p>多家研究公司最近对 HNGE 发表了看法。华尔街 Zen 在 12 月 20 日星期六的报告中将 Hinge Health 的评级从 “持有” 上调至 “买入”。Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Hinge Health 股票的 “卖出（d）” 评级。Evercore ISI 在 10 月 8 日星期三的研究报告中将 Hinge Health 的目标价格从 60.00 美元提高至 65.00 美元，并给予公司 “跑赢大盘” 的评级。Baird R W 在 9 月 5 日星期五的研究报告中将 Hinge Health 的评级提升至 “持有”。最后，巴克莱在 11 月 5 日星期三的报告中将 Hinge Health 的目标价格从 62.00 美元提高至 65.00 美元，并给予公司 “增持” 的评级。一位股票研究分析师给予该股票 “强烈买入” 评级，十五位给予 “买入” 评级，两位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Hinge Health 的共识评级为 “适度买入”，共识目标价格为 59.93 美元。</p>
<p><strong>获取我们关于 HNGE 的最新研究报告</strong></p>
<h2>Hinge Health 的价格表现</h2>
<p>纽约证券交易所 HNGE 在星期五开盘价为 47.57 美元。该公司的 50 日简单移动平均线为 47.59 美元，200 日简单移动平均线为 49.34 美元。Hinge Health 的年内最低价为 33.42 美元，年内最高价为 62.18 美元。</p>
<p>Hinge Health（纽约证券交易所代码：HNGE - 获取免费报告）最后一次发布季度财报是在 11 月 4 日星期二。公司报告季度每股收益为（0.02 美元），超出分析师共识预期的（0.20 美元）0.18 美元。公司季度收入为 1.5421 亿美元，而分析师预期为 1.4244 亿美元。该公司的季度收入同比增长 53.3%。</p>
<p>Hinge Health 宣布其董事会于 11 月 12 日星期三授权了一项股票回购计划，允许公司回购价值 2.5 亿美元的流通股份。该回购授权允许公司通过公开市场购买最多 7.2% 的股票。股票回购计划通常表明公司董事会认为其股票被低估。</p>
<h2>Hinge Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Hinge Health（纽约证券交易所代码：HNGE）是一家数字肌肉骨骼（MSK）诊所，提供预防和管理肌肉骨骼疾病的端到端解决方案。公司的平台结合了可穿戴运动传感器、由持证物理治疗师指导的个性化运动疗法和行为健康辅导，以提供量身定制的治疗计划。通过将技术与基于证据的临床协议相结合，Hinge Health 旨在减轻疼痛、改善活动能力并减少对更具侵入性干预（如手术或阿片类药物处方）的依赖。</p>
<p>Hinge Health 成立于 2015 年，总部位于旧金山，与雇主、健康计划和其他支付方合作，提供其自我导向的应用程序基础项目。</p>
<h2>相关文章</h2>
<ul>
<li>我们更看好的五只股票比 Hinge Health 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>资本利得税是否可以扣除任何费用？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Hinge Health 吗？</h2>
<p>在考虑 Hinge Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Hinge Health 并不在名单上。</p>
<p>虽然 Hinge Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HNGE

<p>Hinge Health Inc.（纽约证券交易所代码：HNGE）在 12 月份的空头头寸增加了 117.4%，总计达到 4,180,660 股。覆盖天数比率为 2.8 天。首席执行官 Daniel Perez 和首席财务官 James Budge 最近出售了大量股份。机构投资者调整了他们的持股，其中一些增加了持股比例。分析师的评级意见不一，普遍共识为 “适度买入”，目标价为 59.93 美元。该股票开盘价为 47.57 美元，50 日均线为 47.59 美元，200 日均线为 49.34 美元</p>

<p>Hinge Health Inc. (NYSE:HNGE - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totaling 4,180,660 shares, an increase of 117.4% from the November 30th total of 1,922,965 shares. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days. Approximately 5.3% of the company's shares are short sold. Approximately 5.3% of the company's shares are short sold. Based on an average daily trading volume, of 1,473,836 shares, the days-to-cover ratio is presently 2.8 days.</p>
<div class="lb-trans"><p>Hinge Health Inc.（纽约证券交易所代码：HNGE - 获取免费报告）在 12 月份的空头头寸显著增加。截至 12 月 15 日，空头头寸总计为 4,180,660 股，比 11 月 30 日的 1,922,965 股增加了 117.4%。根据平均每日交易量 1,473,836 股，目前的覆盖天数比率为 2.8 天。大约 5.3% 的公司股份被做空。</p>
</div><h2>Insider Activity at Hinge Health</h2>
<div class="lb-trans"><h2>Hinge Health 的内部活动</h2>
</div><p>In related news, CEO Daniel Antonio Perez sold 166,670 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $48.53, for a total value of $8,088,495.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO James Budge sold 44,589 shares of the firm's stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $47.47, for a total value of $2,116,639.83. Following the sale, the chief financial officer directly owned 479,878 shares of the company's stock, valued at approximately $22,779,808.66. This trade represents a 8.50% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,638,440 shares of company stock valued at $120,486,691 in the last three months.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Daniel Antonio Perez 于 12 月 15 日星期一出售了 166,670 股公司的股票，交易价格为每股平均 48.53 美元，总价值为 8,088,495.10 美元。该交易在向 SEC 的法律文件中披露，相关文件可通过此链接获取。此外，首席财务官 James Budge 于 11 月 25 日星期二出售了 44,589 股公司的股票，交易价格为每股平均 47.47 美元，总价值为 2,116,639.83 美元。出售后，首席财务官直接持有 479,878 股公司的股票，估值约为 22,779,808.66 美元。此交易代表其持股减少了 8.50%。该销售的 SEC 文件提供了更多信息。在过去三个月中，内部人士共出售了价值 120,486,691 美元的 2,638,440 股公司股票。</p>
</div><h2>Institutional Investors Weigh In On Hinge Health</h2>
<div class="lb-trans"><h2>机构投资者对 Hinge Health 的看法</h2>
</div><p>Large investors have recently modified their holdings of the company. Sandler Capital Management grew its stake in shares of Hinge Health by 1.4% during the third quarter. Sandler Capital Management now owns 52,728 shares of the company's stock worth $2,588,000 after purchasing an additional 728 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Hinge Health during the 3rd quarter worth about $37,000. Montag A &amp; Associates Inc. acquired a new position in shares of Hinge Health during the 2nd quarter worth about $41,000. Jones Financial Companies Lllp increased its holdings in shares of Hinge Health by 348.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company's stock valued at $54,000 after acquiring an additional 870 shares during the last quarter. Finally, SBI Securities Co. Ltd. acquired a new stake in shares of Hinge Health during the 2nd quarter worth about $48,000.</p>
<div class="lb-trans"><p>大型投资者最近调整了对公司的持股。Sandler Capital Management 在第三季度将其在 Hinge Health 的股份增加了 1.4%。Sandler Capital Management 目前持有 52,728 股公司的股票，价值 2,588,000 美元，此前在上个季度购买了 728 股。Mirae Asset Global Investments Co. Ltd.在第三季度购买了 Hinge Health 的新股份，价值约 37,000 美元。Montag A &amp; Associates Inc.在第二季度获得了 Hinge Health 的新头寸，价值约 41,000 美元。Jones Financial Companies Lllp 在第三季度将其在 Hinge Health 的持股增加了 348.0%。Jones Financial Companies Lllp 目前持有 1,120 股公司的股票，估值 54,000 美元，此前在上个季度增加了 870 股。最后，SBI Securities Co. Ltd.在第二季度获得了 Hinge Health 的新股份，价值约 48,000 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级与降级</h2>
</div><p>A number of research firms have recently weighed in on HNGE. Wall Street Zen upgraded Hinge Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, December 20th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Hinge Health in a research report on Wednesday, October 8th. Evercore ISI boosted their price target on shares of Hinge Health from $60.00 to $65.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 8th. Baird R W raised shares of Hinge Health to a &#34;hold&#34; rating in a research report on Friday, September 5th. Finally, Barclays lifted their target price on shares of Hinge Health from $62.00 to $65.00 and gave the company an &#34;overweight&#34; rating in a report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $59.93.</p>
<div class="lb-trans"><p>多家研究公司最近对 HNGE 发表了看法。华尔街 Zen 在 12 月 20 日星期六的报告中将 Hinge Health 的评级从 “持有” 上调至 “买入”。Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Hinge Health 股票的 “卖出（d）” 评级。Evercore ISI 在 10 月 8 日星期三的研究报告中将 Hinge Health 的目标价格从 60.00 美元提高至 65.00 美元，并给予公司 “跑赢大盘” 的评级。Baird R W 在 9 月 5 日星期五的研究报告中将 Hinge Health 的评级提升至 “持有”。最后，巴克莱在 11 月 5 日星期三的报告中将 Hinge Health 的目标价格从 62.00 美元提高至 65.00 美元，并给予公司 “增持” 的评级。一位股票研究分析师给予该股票 “强烈买入” 评级，十五位给予 “买入” 评级，两位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Hinge Health 的共识评级为 “适度买入”，共识目标价格为 59.93 美元。</p>
</div><p><strong>Get Our Latest Research Report on HNGE</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 HNGE 的最新研究报告</strong></p>
</div><h2>Hinge Health Price Performance</h2>
<div class="lb-trans"><h2>Hinge Health 的价格表现</h2>
</div><p>NYSE HNGE opened at $47.57 on Friday. The firm has a 50 day simple moving average of $47.59 and a 200-day simple moving average of $49.34. Hinge Health has a one year low of $33.42 and a one year high of $62.18.</p>
<div class="lb-trans"><p>纽约证券交易所 HNGE 在星期五开盘价为 47.57 美元。该公司的 50 日简单移动平均线为 47.59 美元，200 日简单移动平均线为 49.34 美元。Hinge Health 的年内最低价为 33.42 美元，年内最高价为 62.18 美元。</p>
</div><p>Hinge Health (NYSE:HNGE - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analysts' expectations of $142.44 million. The firm's quarterly revenue was up 53.3% compared to the same quarter last year.</p>
<div class="lb-trans"><p>Hinge Health（纽约证券交易所代码：HNGE - 获取免费报告）最后一次发布季度财报是在 11 月 4 日星期二。公司报告季度每股收益为（0.02 美元），超出分析师共识预期的（0.20 美元）0.18 美元。公司季度收入为 1.5421 亿美元，而分析师预期为 1.4244 亿美元。该公司的季度收入同比增长 53.3%。</p>
</div><p>Hinge Health announced that its board has authorized a share buyback program on Wednesday, November 12th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 7.2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.</p>
<div class="lb-trans"><p>Hinge Health 宣布其董事会于 11 月 12 日星期三授权了一项股票回购计划，允许公司回购价值 2.5 亿美元的流通股份。该回购授权允许公司通过公开市场购买最多 7.2% 的股票。股票回购计划通常表明公司董事会认为其股票被低估。</p>
</div><h2>Hinge Health Company Profile</h2>
<div class="lb-trans"><h2>Hinge Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.</p>
<div class="lb-trans"><p>Hinge Health（纽约证券交易所代码：HNGE）是一家数字肌肉骨骼（MSK）诊所，提供预防和管理肌肉骨骼疾病的端到端解决方案。公司的平台结合了可穿戴运动传感器、由持证物理治疗师指导的个性化运动疗法和行为健康辅导，以提供量身定制的治疗计划。通过将技术与基于证据的临床协议相结合，Hinge Health 旨在减轻疼痛、改善活动能力并减少对更具侵入性干预（如手术或阿片类药物处方）的依赖。</p>
</div><p>Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.</p>
<div class="lb-trans"><p>Hinge Health 成立于 2015 年，总部位于旧金山，与雇主、健康计划和其他支付方合作，提供其自我导向的应用程序基础项目。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Hinge Health</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Do you know what Amazon is planning for January 1?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Hinge Health 更好</li>
<li>请勿删除，立即阅读</li>
<li>投资者警报：微型 “3 美元 AI 奇迹股票” 即将爆发</li>
<li>资本利得税是否可以扣除任何费用？</li>
<li>你知道亚马逊计划在 1 月 1 日做什么吗？</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Hinge Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Hinge Health 吗？</h2>
</div><p>Before you consider Hinge Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Hinge Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Hinge Health 并不在名单上。</p>
</div><p>While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hinge Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Hinge Health Inc. (NYSE:HNGE) 的空头头寸更新